BAUSCH + LOMB CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.12 USD | +2.23% |
|
+3.28% | -11.37% |
Chart calendar Bausch + Lomb Corporation
5e7090b2107d54e3dfd77ef39d63d.3EUyDS6f4FQVaiHI6ki8N07mm2jExamKoDdkrrrDvcU.6iwDVWTMtCwsLxGnpSPWDxiX_h-yqs3V6Ac-nYugi-iENER9beexF10GYA~ee6a4ef69886eb2a758f9b07eddc55ce
Upcoming events on Bausch + Lomb Corporation
Past events on Bausch + Lomb Corporation
| 07/04/2024 07:30 pm | American Society of Cataract and Refractive Surgery Meeting |
| 07/04/2024 04:00 am | American Society of Cataract and Refractive Surgery Meeting |
| 07/04/2024 12:30 am | American Society of Cataract and Refractive Surgery Meeting |
| 06/04/2024 04:45 am | American Society of Cataract and Refractive Surgery Meeting |
| 21/02/2024 06:30 pm | Q4 2023 Earnings Call |
| 21/02/2024 05:28 pm | Q4 2023 Earnings Release |
| 09/01/2024 12:45 am | JPMorgan Healthcare Conference |
| 06/11/2023 02:30 am | American Academy Of Ophthalmology Meeting |
| 06/11/2023 01:40 am | American Academy Of Ophthalmology Meeting |
| 05/11/2023 06:30 am | American Academy Of Ophthalmology Meeting |
| 05/11/2023 02:30 am | American Academy Of Ophthalmology Meeting |
| 05/11/2023 12:40 am | American Academy Of Ophthalmology Meeting |
| 04/11/2023 08:00 am | American Academy Of Ophthalmology Meeting |
| 01/11/2023 05:30 pm | Q3 2023 Earnings Call |
| 01/11/2023 04:28 pm | Q3 2023 Earnings Release |
| 14/10/2023 07:00 am | American Academy of Optometry Meeting - A New Orleans Nightcap with LUMIFY EYE ILLUMINATIONS |
| 13/10/2023 06:30 pm | American Academy of Optometry Meeting - MIEBO |
| 13/10/2023 03:30 am | American Academy of Optometry Meeting - Fighting the Battle in the Rx Treatment |
| 12/10/2023 06:30 pm | American Academy of Optometry Meeting - Innovations in Inflammation and IOP Control |
| 12/10/2023 06:30 pm | American Academy of Optometry Meeting - Introducing New LUMIFY EYE ILLUMINATIONS |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 765 | 3 768 3 743 0.66% | 4 146 4 075 1.73% | 4 659 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 720 733 -1.76% | 738 728 1.41% | 869 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | 585 525 11.53% | 596 532 11.94% | 647 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 73,0 105 -30.7% | -166 -132 -25.76% | -96,3 |
|
Net income Million USD | Released Forecast Spread | 182 | 6,00 49,7 -87.92% | -260 -216 -20.65% | -143 |
|
EPS USD | Released Forecast Spread | 0,00 | 0,02 0,20 -89.74% | -0,74 -0,61 -20.52% | -0,28 |
| Announcement Date | 31/03/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 889 889 0% | 941 909 3.53% | 942 950 -0.82% | 996 964 3.33% | 931 894 4.18% | 1 035 966 7.18% | 1 007 990 1.7% | 1 173 1 104 6.25% | 1 068 | 1 175 | 1 162 | 1 255 | 1 111 |
|
EBITDA Million USD | Released Forecast Spread | 170 170 0% | 182 173 5.22% | 187 190 -1.71% | 181 198 -8.42% | 141 154 -8.25% | 179 163 9.8% | 187 184 1.66% | 231 226 2.13% | 177 | 213 | 219 | 258 | 169 |
|
EBIT Million USD | Released Forecast Spread | 140 123 14.29% | 148 125 18.52% | 153 139 10.39% | 144 142 1.39% | 107 94,3 13.46% | 104 108 -3.57% | 152 106 43.74% | 195 167 16.76% | 118 | 157 | 163 | 204 | 117 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 29,0 29,0 0% | 27,0 -12,0 325% | 19,0 62,0 -69.33% | -2,00 48,3 -104.14% | -55,0 5,00 -1200% | -19,0 -36,0 47.22% | -35,0 -27,0 -29.63% | -57,0 -23,7 -140.85% | -45,0 | -29,0 | -20,7 | -1,67 | |
|
Net income Million USD | Released Forecast Spread | 20,0 20,0 0% | 5,00 4,60 8.7% | -18,0 53,1 -133.88% | -1,00 46,6 -102.15% | -90,0 -2,33 -3757.15% | -32,0 -11,0 -191.79% | -84,0 -35,3 -137.74% | -54,0 -13,0 -315.38% | -55,7 | -41,7 | -32,3 | -13,7 | |
|
EPS USD | Released Forecast Spread | 0,06 0,06 5.01% | 0,01 0,09 -88.65% | -0,05 0,13 -137.88% | 0,00 0,09 - | -0,26 -0,01 -1980% | -0,09 -0,03 -200% | -0,24 -0,04 -500% | -0,15 -0,08 -100% | -0,15 | -0,10 | -0,07 | 0,00 | |
| Announcement Date | 08/06/22 | 04/08/22 | 02/11/22 | 22/02/23 | 03/05/23 | 02/08/23 | 01/11/23 | 21/02/24 | - | - | - | - | - |
| Today 01:35 am | SILK ROAD MEDICAL, INC: Q1 2024 Earnings Release |
| Today 01:35 am | MERIT MEDICAL SYSTEMS, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | REPLIGEN CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | BAUSCH + LOMB CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | PROCEPT BIOROBOTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 03:30 pm | LIVANOVA PLC: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | CENCORA, INC.: Q2 2024 Earnings Release |
| 02/05/2024 01:31 am | ATRICURE, INC.: Q1 2024 Earnings Release |
| 02/05/2024 01:40 am | ENVISTA HOLDINGS CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 | TANDEM DIABETES CARE, INC.: Q1 2024 Earnings Release |
Past sector events for Bausch + Lomb Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BLCO Stock
- Calendar Bausch + Lomb Corporation
